Qiagen’s outgoing chief executive Thierry Bernard, M.D., told investors the company does not “comment on rumors” as takeover talks swirl around the diagnostics specialist. Buyout speculation has been ...
Qiagen stock moves and recent performance snapshot Qiagen (QGEN) has drawn investor attention after recent price movements, ...
Qiagen (NYSE:QGEN) said it closed 2025 with fourth-quarter results that came in above its outlook, while highlighting growth across key product lines and progress on profitability and cash generation ...
Business: Qiagen NV is a holding company based in the Netherlands. The company provides "Sample to Insight" solutions that transform biological samples into molecular insights. These solutions ...
VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of EZ2 Connect MDx for use in diagnostic laboratories, making the IVD platform ...
VENLO, Netherlands, November 04, 2025--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the third quarter of 2025 and reaffirmed its outlook for ...
The news is coming thick and fast for Qiagen. As the molecular diagnostics specialist announced its third-quarter earnings, it also revealed that its long-term chief executive, Thierry Bernard, will ...
REDWOOD CITY, Calif. & VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN, Frankfurt Prime Standard: QIA) today announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new ...
Activist investor Fivespan Partners has accumulated a position in Dutch diagnostics firm Qiagen NV (NYSE:QGEN). The activist investor has had constructive talks with Qiagen's management team, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results